Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients

Clinical Cancer Research

Volumn 8, Issue 9, 2002, Pages 2782-2787

  Conry, Robert M ^a   Curiel, David T ^b   Strong, Theresa V ^a   Moore, Susan E ^a   Allen, Karen O ^a   Barlow, Daunte L ^a   Shaw, Denise R ^a   LoBuglio, Albert F ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; COMPLEMENTARY DNA; CREATINE KINASE; DNA VACCINE; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ANEMIA; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FEMALE; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; INJECTION PAIN; LYMPHOCYTE PROLIFERATION; MALE; METASTASIS; PLASMID; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; ANEMIA; ANTIGENS, NEOPLASM; C-REACTIVE PROTEIN; CANCER VACCINES; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; CREATINE KINASE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOTHERAPY, ACTIVE; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PILOT PROJECTS; SAFETY; VACCINES, DNA;

EID: 0036716966     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Direct gene transfer into mouse muscle in vivo
2. Genetic immunization is a simple method for eliciting an immune response
3. Heterologous protection against influenza by injection of DNA encoding a viral protein
4. DNA vaccines
5. DNA vaccines
6. First human trial of a DNA-based vaccine for treatment of human immuno-deficiency virus type 1 infection: Safety and host response
7. Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial
8. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients
9. AVEG 031: Phase I evaluation of a gag-pol facilitated DNA vaccines for HIV-1 prevention
10. Safety and immunogenicity of influenza hemagglutinin DNA vaccine alone or with aluminum adjuvant in adult volunteers
11. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine
12. Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives
13. Immune response to a carcinoembryonic antigen polynucleotide vaccine
14. A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity
15. Polynucleotide immunization of non-human primates against carcinoembryonic antigen
16. Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line
17. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody
18. Direct gene transfer in skeletal muscle: Plasmid DNA-based immunization against the hepatitis B virus surface antigen
19. A carcinoembryonic antigen polynucleotide vaccine for human clinical use
20. Pharmacological enhancement of in vivo foreign gene expression in muscle
21. Clinical protocol: Phase 1a trial of a polynucleotide anti-tumor immunization to human carcinoembryonic antigen in patients with metastatic colorectal cancer
22. Interpretation of various serological profiles of hepatitis B virus infection
23. Human autoantibodies to carcinoembryonic antigen induced by a vaccinia-CEA vaccine
24. The acute phase response
25. Non-specific cross-reacting antigen: Characterization of specific and cross-reacting epitopes
26. Potential for plasmid DNAs as vaccines for the new millennium
27. Naked DNA adenoviral immunizations for immunotherapy of prostate cancer: A Phase I/II clinical trial
28. Phase I safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device
29. Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine
30. Transmissibility of murine stem cell virus-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene: Implications for immune gene therapy
31. Hepatitis B virus-reactive human T lymphocyte clones: Antigen specificity and helper function for antibody synthesis
32. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: Stimulation of the in vitro antibody response by interferon gamma
33. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection
34. Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: Comparison of intradermal versus subcutaneous administration
35. Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: A review
36. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine
37. Clinical and immune response in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen
38. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
39. The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma
40. Melanoma vaccines: The paradox of T cell activation without clinical response
41. Prime-boost immunization strategies for infectious disease